Sage Journals: Discover world-class research

Abstract

Cellular immune responses play a critical role in the control of human immunodeficiency virus type 1 (HIV-1), but less is known about the impact of transmission routes on immune defenses against HIV-1. Here, we report that subjects infected with HIV-1 through contaminated blood showed stronger HIV-specific T cell responses than those infected through mucosa, both in breadth (6.9±2.5 vs. 2.3±0.5, p=0.0293) and in magnitude [1270.0±544.9 vs. 409.5±121.3 SFU per million peripheral blood mononuclear cells (PBMCs), p=0.0223], by using a matrix of 404 overlapping peptides spanning all expressed HIV-1 proteins in an interferon (IFN)-γ enzyme-linked immunospot (ELISpot) assay. Our observation indicates that different mechanisms might be involved in the priming/generating of anti-HIV-specific T cell responses through different transmission routes.

Get full access to this article

View all access options for this article.

References

McMichael

, Rowland-Jones

. Cellular immune responses to HIV. Nature, 2001; 410:980–987.

Shattock

, Moore

. Inhibiting sexual transmission of HIV-1 infection. Nat Rev Microbiol, 2003; 1:25–34.

Wawer

, Gray

, Sewankambo

et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis, 2005; 191:1403–1409.

Keele

, Giorgi

, Salazar-Gonzalez

et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci USA, 2008; 105:7552–7557.

Roederer

, Koup

. Optimized determination of T cell epitope responses. J Immunol Methods, 2003; 274:221–228.

Goonetilleke

, Moore

, Dally

et al. Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag coupled to CD8+ T-cell epitopes. J Virol, 2006; 80:4717–4728.

Addo

, Yu

, Rathod

et al. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol, 2003; 77:2081–2092.

Abrahams

, Anderson

, Giorgi

et al. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-Poisson distribution of transmitted variants. J Virol, 2009; 83:3556–3567.

Kaufman

, Bivas-Benita

, Simmons

, Miller

, Barouch

. Route of adenovirus-based HIV-1 vaccine delivery impacts the phenotype and trafficking of vaccine-elicited CD8+ T lymphocytes. J Virol, 2010; 84:5986–5996.

10.

Gray

, Lawrence

, Schapiro

et al.

Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART)

J Immunol, 1999; 162:1780–1788.

11.

Kalams

, Goulder

, Shea

et al. Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy. J Virol, 1999; 73:6721–6728.

12.

Ogg

, Jin

, Bonhoeffer

et al. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J Virol, 1999; 73:797–800.

Short Communication: Broader T Cell Responses Directed Against Human Immunodeficiency Virus Type 1 in Infected Chinese Individuals Through Blood-Borne Transmission in Comparison with Mucosal Transmission

Abstract

Get full access to this article

References